Zum Thema
Die intestinale Metaplasie im distalen Ösophagus wird als Folge einer langjährigen Refluxkrankheit angesehen. Dieses Barrett-Epithel birgt in Folge einer Dysplasie-Karzinom-Sequenz ein erhöhtes Risiko für ein Adenokarzinom der Speiseröhre. Zur Therapie stehen endoskopische Methoden auf dem Prüfstand, deren Vorteile gegenüber chirurgischen Verfahren in der geringeren Komplikationsrate und geringen Invasivität liegen. Die verschiedenen Formen der thermischen Ablation und die bisherigen Studienergebnisse werden in der folgenden Übersichtsarbeit vorgestellt. Dabei ist die Bewertung der verschiedenen Methoden besonders hinsichtlich des präventiven Einsatzes in Bezug auf das Adenokarzinom noch nicht vollständig abgeschlossen.
Literatur
Spechler SJ (2002) Barrett's esophagus. N Engl J Med 346: 836–842
Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS (2000) Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119: 333–338
Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ (2002) Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97: 1930–1936
Sampliner RE (2002) Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 97: 1888–1895
Canto MI, Setrakian S, Willis J et al. (2001) Methylene blue staining of dysplasia and nondysplastic Barrett's esophagus. An in and ex vivo study. Endoscopy 33: 391–401
Schnell TG, Sontag SJ, Chejfec G et al. (2001) Long-term nonsurgical management of Barrett's esophagus with high grade dysplasia. Gastroenterology 120: 1607–1619
Peters FT, Ganesh S, Kuipers EJ, Sluiter WJ, Klinkenberg-Knol EC, Lamers CB, Kleibuker JH (1999) Endoscopic regression of Barrett's esophagus during omeprazole treatment: a randomized double blind study. Gut 45: 489–494
Malesci A, Savarino V, Zentilin P et al. (1996) Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc 44: 700–705
Ouatu-Lascar R, Triadafilopoulos G (1998) Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus. Am J Gastroenterol 93: 711–716
Haag S, Nandukar S, Talley N (1999) Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods. Gastrointest Endosc 50: 229–240
Low DE, Levine DS, Dail DH, Kozarek RA (1999) Histological and anatomic changes in Barrett's esophagus after antireflux surgery. Am J Gastroenterol 94: 80–85
Sharma P Bhattacharyya A, Garewal HS, Sampliner RE (1999) Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus. Gastrointest Endosc 50: 159–164
Brand B, Porthun M, von Schrenck T et al. (2000) Endoscopic argonplasma coagulation for eradication of Barrett's epithelium. Zentralbl Chir 125: 437–442
Grade AJ, Shah IA Medlin SM, Ramirez FC (1999) The efficiacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc 50: 18–22
Michopoulos S, Tsibouris P, Bouzakis H, Sotiropoulou M, Kralios N (1999) Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc 50: 165–172
Van Laethem JL, Cremer M, Peny MO, Delhaye M, Devière J (1998) Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 43: 747–751
Schulz H, Michlke S, Antos D et al. (2000) Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high dose omeprazole. Gastrointest Endosc 51: 659–663
Sampliner RE, Faigel D, Fennerty B, Lieberman D, Ippoliti A, Lewin K, Weinstein WM (2001) Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study. Gastrointest Endosc 53: 554–558
Bremner CG, Lynch VP, Ellis FH (1970) Barrett's esophagus: congenital or acquired? An experimental study of oesophageal mucosal regeneration in the dog. Surgery 68: 209–216
Byrne JP, Armstrong GR, Attwood SEA (1998) Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation. Am J Gastroenterol 93: 1810–1815
Van Laethem JL, Peny, MO, Salmon I, Cremer M, Devière J (2000) Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 46: 574–577
Shand A, Dallal H, Palmer K, Ghosh S, MacIntyre M (2001) Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 48: 580–581
Van den Boogert J, van Hillegersberg R, Siersema PD, de Bruin RWF, Tilanus HW (1999) Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review. Am J Gastroenterol 94: 1153–1160
Overholt BF, Panjehpour M, Haydek JM (1999) Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 49: 1–7
Gossner L, May A, Sroka R, Stolte M, Hahn EG, Ell C (1999) Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolaevulinic acid. Cancer 86: 1921–1928
Sharma P, Jaffe PE, Bhattacharyya A, Sampliner RE (1999) Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up. Gastrointest Endosc 49: 442–446
Ackroyd R, Brown NJ, Davis MF et al. (2000) Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 47: 612–617
Buttar NS, Wang KK, Lutzke LS, Krishnadath KK, Anderson MA (2001) Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus. Gastrointest Endosc 54: 682–688
Ell C, May A, Gossner L et al. (2000) Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 118: 670–677
Van Laethem JL, Jagododzinski R, Peny MO et al. (2001) Argon plasma coagulation in the treatment of Barrett's high grade dysplasia and in situ carcinoma. Endoscopy 33: 257–261
Gossner L, May A, Stolte M, Seitz G, Ell C (1999) KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc 49: 8–12
May A, Gossner L, Günter E, Stolte M, Ell C (1999) Local treatment of early cancer in short Barrett's esophagus by means of argon plasma coagulation. Endoscopy 31: 497–500
May A, Gossner L, Günter E, Mayer G, Seitz G, Vieth M, Stolte M, Ell C (2002) Local endoscopic treatment for intraepithelial high-grade neoplasia and early cancer of Barrett's esophagus: Acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 14: 1085–1091
Stein HJ, Feith M, Mueller J, Werner M, Siewert JR (2000) Limited resection for early adenocarcinoma in Barrett's esophagus. Ann Surg 232: 732–742
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, M., Ell, C. Barrett-Ösophagus: ablative Behandlungsmethoden. Internist 44, 52–57 (2003). https://doi.org/10.1007/s00108-002-0809-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-002-0809-0